Cipher Mining to Participate in the 4th Annual Needham Virtual Crypto Conference
NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) — Cipher Mining Inc. (NASDAQ: CIFR) (“Cipher” or the “Company”), a U.S.-based Bitcoin […]
Aura Biosciences to Participate in Upcoming Investor Conferences
BOSTON, Aug. 28, 2024 (GLOBE NEWSWIRE) — Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies to treat […]
HeartCore to Present at the H.C. Wainwright 26th Annual Global Investment Conference on September 11, 2024
NEW YORK and TOKYO, Aug. 28, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a […]
Dave & Buster’s Entertainment, Inc. to Report Second Quarter 2024 Financial Results on September 10, 2024
DALLAS, Aug. 28, 2024 (GLOBE NEWSWIRE) — Dave & Buster’s Entertainment, Inc., (NASDAQ:PLAY), (“Dave & Buster’s” or “the Company”), an […]
Pool Corporation Announces Upcoming Investor Conference Participation
COVINGTON, La., Aug. 28, 2024 (GLOBE NEWSWIRE) — Pool Corporation (Nasdaq: POOL) announced today that it will participate in the […]
Inotiv to Participate in the 8th Annual Lake Street Best Ideas Growth Conference
WEST LAFAYETTE, Ind., Aug. 28, 2024 (GLOBE NEWSWIRE) — Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in […]
Methode Electronics Appoints Laura Kowalchik as Chief Financial Officer
CHICAGO, Aug. 28, 2024 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for […]
Partnerschaft für Begleitdiagnostika für chronische Krankheiten: QIAGEN weitet Anwendung von QIAstat-Dx auf die Präzisionsmedizin aus
Neue Vereinbarung erweitert die Zusammenarbeit mit AstraZeneca über die Onkologie hinaus – einschließlich komplexer chronischer Erkrankungen // QIAGENs syndromische Testplattform […]
QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in chronic diseases
Venlo, the Netherlands, Aug. 28, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion […]
ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) — ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief […]
